Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 4, 2004, Pages 451-457

  Mañas, Eva ^a   Pulido, F ^b   Pena J M ^c   Rubio, R ^b   Gonzalez Garcia J ^c   Costa, R ^b   Perez Rodriguez E ^a   Del Palacio, A ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

CD4 T lymphocytes; HIV infection; Prognosis; Tuberculosis

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LYMPHOCYTE COUNT; MALE; OBSERVATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUBERCULOSIS;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 2442476557     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Whalen C C, Horsburgh R C, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of HIV infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
2. Perneger T, Sudre P, Lundgren J, Hirschel B. Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. BMJ 1995; 311: 1468-1471.
3. Leroy V, Salmi R, Dupon M, et al. Progression of human immunodeficiency virus in patients with tuberculosis disease. Am J Epidemiol 1997; 145: 293-300.
4. Munsiff S, Alpert P, Gourevitch M, Chang C, Klein R. A prospective study of tuberculosis and VIH disease progression. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 361-366.
5. Dean G L, Edwards S G, Ives N J, et al. Treatment of tuberculosis in VIH-infected persons in the era of highly active antiretroviral therapy. AIDS 2002; 16: 75-83.
6. Girardi E, Palmieri F, Cingolani A, et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 26: 326-331.
7. Stoneburner R, Laroche E, Prevots R, et al. Survival in a cohort of Human Immunodeficiency Virus-infected tuberculosis patients in New York City. Arch Intern Med 1992; 152: 2033-2037.
8. Cervero M, Medina Asensio J, Rubio R, Costa J R. An epidemiological and immunological study of HIV infection in the southern area of Madrid. Rev Clin Esp 1991; 188: 17-23.
9. Moore R D, Keruly J, Richman D D, Creagh Kirk T, Chaisson R E. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group. AIDS 1992; 6: 671-677.
10. Whalen C C, Okwera A, Johnson J, et al. Predictors of survival in HIV infected patients with pulmonary tuberculosis. Am J Respir Crit Care Med 1996; 153: 1977-1981.
11. 4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946-954.
12. Richter C, Koelemay M J, Swai A B, Perenboom R, Mwakyusa D H, Oosting J. Predictive markers of survival in HIV-seropositive Tanzanian patients with extrapulmonary tuberculosis. Tubercle Lung Dis 1995; 76: 510-517.
13. Alpert P L, Munsiff S S, Gourevitch M N, Greenberg B, Klein R S. A prospective study of tuberculosis and HIV infection: clinical manifestations and factors associated with survival. Clin Infect Dis 1997; 24: 661-668.
14. Whalen C C, Nsubuga P, Okwera A, et al. Impact of pulmonary tuberculosis on survival of HIV infected adults: a prospective epidemiologic study in Uganda. AIDS 2000; 14: 1219-1228.
15. Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Association between tuberculosis and VIH disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis 2001; 5: 205-207.
16. 4 + lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 386-391.
17. 4 + T lymphocyte depletion in patients without HIV infection treated for tuberculosis. Chest 1994; 105: 1335-1337.
18. 4 cell counts in HIV-negative patients with tuberculosis. Clin Infect Dis 1997; 24: 988-991.
19. 4 + T lymphocytopenia in severe pulmonary tuberculosis without evidence of HIV infection. Int J Tuberc Lung Dis 1997; 1: 422-426.
20. 4 lymphopenia in patients with active pulmonary tuberculosis. Clin Exp Immunol 1985; 60: 49-54.
21. Del Amo J, Malin A, Pozniak A, De Cock K. Does tuberculosis accelerate the progression of disease? Evidence from basic science and epidemiology. AIDS 1999; 13: 1151-1158.
22. Goletti D, Weismann D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996; 157: 1271-1278.
23. Toosi Z, Sierra-Madero J, Blinkhorn R, Mettler M, Rich E. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with HIV-1. J Exp Med 1993; 117: 1511-1516.
24. Nakata K, Rom W N, Honda Y, et al. Mycobacterium tuberculosis enhances HIV-1 replication in the lung. Am J Respir Crit Care Med 1997; 155: 996-1003.
25. Wallis R S, Amir-Tamhmasseb M A, Elner J J. Induction of the IL-1 and TNF by micobacterial proteins: the monocyte Western blot. Proc Natl Acad Sci USA 1990; 87: 3348-3352.
26. Wallis R S, Fujiwara H, Ellner J J. Direct stimulation of monocyte release of IL-1 by mycobacterial protein antigens. J Immunol 1986; 136: 193-196.
27. Chensue S W, Davey M P, Resnick D G, Kunkel S L. Release of IL-1 bl peripheral blood mononuclear cells in patients with tuberculosis and active inflammation. Infect Immun 1986; 52: 341-343
28. Barnes P F, Chatterjee D, Abrams J S, et al. Cytokine production induced by micobacterium tuberculosis lipoarabinomannan. J Immunol 1992; 149: 541-547.
29. Zhang Y, Doerfler Y M, Lee T C, Guillemin B, Rom W N. Mechanisms of stimulation of IL-1β and TNF-α by Mycobacterium tuberculosis components. J Clin Invest 1993; 91: 2076-2083.
30. Garrait V, Cadranel J, Esvant H, et al. Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J Immunol 1997; 159: 2824-2830.
31. Ogawa T H, Uchida T H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in TNF-α and IL-6 secreting cells in peripheral blood mononuclear cells from subjects infected with M. tuberculosis. Infect Immun 1991; 59: 3021-3025.
32. Valone S E, Rich E A, Wallis R S, Ellner J J. Expression of TNF in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immune 1988; 56: 3313-3315.
33. Takashima T, Ueta C, Tsuyuguchi I, Kishimoto S. Production of TNF-α by monocytes from patients with pulmonary tuberculosis. Infect Immun 1990; 58: 3286-3292
34. 2-microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993; 167: 43-48.
35. Duh E J, Maury W, Folks T, Fauci A, Rabson A. TNF-α activates HIV-1 through induction of nuclear factor binding to the NF-6B sites in the long terminal repeat. Proc Natl Acad Sci USA 1989; 86: 5974-5978.
36. Poli G, Kinter A, Justement J S, et al. TNF-α functions in an autocrine manner in the induction of HIV expression. Proc Natl Acad Sci USA 1990; 87: 782-785.
37. Osborn L S, Kunkel S, Nabel G J. TNF-α and IL-1 stimulate the HIV enhancer by activation of the nuclear factor κβ. Proc Natl Acad Sci USA 1989; 86: 5974-5978.
38. Greene W C. The molecular biology HIV-1 infection. N Engl J Med 1991; 234: 308-317.
39. Nabel G, Baltimore D. An inducible transcription factor activates expression of HIV in T cells. Nature 1987; 326: 711-713.
40. Tong-Starksen S E, Luciw P A, Peterlin B M. HIV long terminal repeat responds to T cell activation signals. Proc Natl Acad Sci USA 1987; 84: 6845-6849.
41. Sullivan P S, Hanson D L, Chu S Y, Jones J L, Ward J W. Epidemiology of anemia in HIV infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998; 91: 301-308.
42. Moore R D, Keruly J C, Chaisson R E. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 29-33.
43. Mocroft A, Kirk O, Barton S E, et al. Anemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS 1999; 943-950.
44. Bacchetti P, Moss A R, Andrews J C, Jacobson M A. Early predictors of survival in symptomatic HIV infected persons treated with high dose zidovudine. J Acquire Immune Defic Syndr 1992; 5: 732-736.
45. Blatt S P, McCarthy W F, Bucko-Krasnicka B, et al. Multivariate models for predicting progression to AIDS and survival in HIV infected persons. J Infect Dis 1995; 171: 837-844.
46. Muñoz A, Vlahov D, Solomon L, et al. Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1992; 5: 694-700.